Answer to Question 1
C
Feedback:
The drugs used to treat patients with myasthenia gravis include several indirect-acting cholinergic agonists that do not cross the bloodbrain barrier and do not effect acetylcholine transmission in the brain. These drugs include ambenonium (Mytelase), edrophonium (Enlon, Reversol), neostigmine (Prostigmin), and pyridostigmine (Mestinon). Other options are incorrect.
Answer to Question 2
C
Feedback:
Being alert to adverse effectswhat to assess and how to intervene appropriatelycan increase the effectiveness of a drug regimen, provide for patient safety, and improve patient compliance. Indications of allergic reactions would not indicate noncompliance or improve effectiveness of a specific medication. Indications of allergic reaction would indicate an adverse effect and would not reduce the risk.